 |
|
The Correlation Between Ventricular Diameter Measured by Transcranial Sonography and Clinical Disability and Cognitive Dysfunction in Patients With Multiple Sclerosis
Daniela Berg, MD;
Mathias Mäurer, MD;
Monika Warmuth-Metz, MD;
Peter Rieckmann, MD;
Georg Becker, MD
Arch Neurol. 2000;57:1289-1292.
Context Magnetic resonance imaging (MRI) data suggest that the extent of brain atrophy in patients with multiple sclerosis (MS) is related to the severity of disease.
Objective To evaluate whether ventricular diameter determined by transcranial sonography (TCS) is a marker of brain atrophy and is correlated with disability, cognitive performance, and mood.
Subjects and Methods We examined 74 subjects with MS and 74 age- and sex-matched control subjects with TCS and assessed the transverse diameter of the third ventricle and the frontal horns of the lateral ventricles. Quantitative neurological examination was performed in subjects with MS using the Expanded Disability Status Scale. All subjects with MS underwent MRI, the Brief Repeatable Battery of Neuropsychological Tests for MS, and standardized tests for mood disorders.
Results Transcranial sonographic measurements of ventricular diameter closely matched MRI measurements (Spearman rank correlation, r=0.7-0.9; P<.01). The ventricular diameters were significantly larger in subjects with MS than in healthy age- and sex-matched control subjects. The measurement of the diameter of the third ventricle obtained by TCS or MRI and the measurement of disability obtained with the Expanded Disability Status Scale were significantly correlated (Spearman rank correlation, r = 0.4; P<.01). The correlation between the diameter of the frontal horns and disability was substantially lower for both neuroimaging techniques. In addition, TCS and MRI data correlated significantly with the majority of neuropsychological tests; no correlation was found between the diameter of the ventricles and depression scales.
Conclusion As ventricular diameter is related to the status of disability and may also indicate disease progression, we propose measurement of the diameter of the third ventricle with TCS as a quick and easy surrogate marker for serial follow-up examinations in patients with MS.
From the Department of Neurology (Drs Berg, Mäurer, Rieckmann, and Becker) and the Division of Neuroradiology (Dr Warmuth-Metz), Bayerische Julius-Maximilians-Universität, Würzburg, Germany.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLES
Ultrasound Measurement of Brain Atrophy in Multiple Sclerosis
Donald W. Paty
Arch Neurol. 2000;57(9):1264.
EXTRACT
| FULL TEXT
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2000;57(9):1387-1388.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns
Tiemann et al.
Mult Scler 2009;15:1164-1174.
ABSTRACT
Transcranial brain sonography findings predict disease progression in multiple sclerosis
Walter et al.
Neurology 2009;73:1010-1017.
ABSTRACT
| FULL TEXT
Transcranial sonography of deep gray nuclei: A new outcome measure in multiple sclerosis?
Pirko and Zivadinov
Neurology 2009;73:1006-1007.
FULL TEXT
Iron Particle-Enhanced Visualization of Inflammatory Central Nervous System Lesions by High Resolution: Preliminary Data in an Animal Model
Linker et al.
Am. J. Neuroradiol. 2006;27:1225-1229.
ABSTRACT
| FULL TEXT
Third Ventricle Enlargement Among Newborn Infants With Trisomy 21
Schimmel et al.
Pediatrics 2006;117:e928-e931.
ABSTRACT
| FULL TEXT
Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study
Versijpt et al.
Mult Scler 2005;11:127-134.
ABSTRACT
Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy
Walter et al.
Neurology 2004;63:504-509.
ABSTRACT
| FULL TEXT
Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients
Christodoulou et al.
Neurology 2003;60:1793-1798.
ABSTRACT
| FULL TEXT
Ultrasound Measurement of Brain Atrophy in Multiple Sclerosis
Paty
Arch Neurol 2000;57:1264-1264.
FULL TEXT
|
